ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.65
-2.06 (-15.03%)
At close: Mar 9, 2026, 4:00 PM EDT
11.80
+0.15 (1.29%)
After-hours: Mar 9, 2026, 7:46 PM EDT
ORIC Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -129.47 | -127.85 | -100.7 | -89.12 | -78.72 | |
| Depreciation & Amortization | 1.22 | 1.11 | 1.03 | 0.97 | 0.9 | |
| Loss (Gain) From Sale of Assets | - | - | 0.02 | 0.04 | 0 | |
| Loss (Gain) From Sale of Investments | -2.3 | -8.1 | -6.17 | -1.04 | 1.35 | |
| Stock-Based Compensation | 25.04 | 20.21 | 15.23 | 14.46 | 12.85 | |
| Change in Accounts Payable | -7.25 | 1.83 | 3.28 | -1.48 | 2.93 | |
| Change in Other Net Operating Assets | 1.79 | 0.14 | 1.62 | 1.03 | 1.14 | |
| Operating Cash Flow | -110.97 | -112.66 | -85.69 | -75.14 | -59.54 | |
| Capital Expenditures | -0.71 | -1.19 | -0.85 | -2.08 | -0.94 | |
| Investment in Securities | -147.32 | 23.33 | -42.55 | -107.17 | 159.37 | |
| Investing Cash Flow | -148.03 | 22.14 | -43.4 | -109.25 | 158.44 | |
| Issuance of Common Stock | 247.66 | 126.72 | 85.89 | 25.62 | 50.99 | |
| Other Financing Activities | -2.4 | -0.17 | -0.23 | -0.4 | -1.85 | |
| Financing Cash Flow | 245.26 | 126.55 | 85.66 | 25.23 | 49.13 | |
| Net Cash Flow | -13.74 | 36.02 | -43.43 | -159.17 | 148.03 | |
| Free Cash Flow | -111.68 | -113.85 | -86.54 | -77.22 | -60.48 | |
| Free Cash Flow Per Share | -1.27 | -1.63 | -1.68 | -1.95 | -1.59 | |
| Levered Free Cash Flow | -69.1 | -67.1 | -49.08 | -42.02 | -32.71 | |
| Unlevered Free Cash Flow | -69.1 | -67.1 | -49.08 | -42.02 | -32.71 | |
| Change in Working Capital | -5.46 | 1.97 | 4.9 | -0.45 | 4.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.